83 related articles for article (PubMed ID: 2293225)
21. [Disordered keratinocyte differentiation in epidermal tumors and mycosis fungoides].
Vavilov AM; Beletskaia LV; Drobyshevakaia EI; Persina IS
Vestn Dermatol Venerol; 1989; (1):26-9. PubMed ID: 2470216
[TBL] [Abstract][Full Text] [Related]
22. Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence.
Simrell CR; Boccia RV; Longo DL; Jaffe ES
Arch Pathol Lab Med; 1986 Nov; 110(11):1029-34. PubMed ID: 3096258
[TBL] [Abstract][Full Text] [Related]
23. [Clinical, histological and immunohistochemical study of the early diagnosis of mycosis fungoides].
Goos M; Eckstein M; Biskup K
Z Hautkr; 1983 Mar; 58(6):373-84. PubMed ID: 6845804
[No Abstract] [Full Text] [Related]
24. Mycosis fungoides with focal CD 30 transformation in an adolescent.
Romero M; Haney M; Desantis E; Zlotoff B
Pediatr Dermatol; 2008; 25(5):565-8. PubMed ID: 18950403
[TBL] [Abstract][Full Text] [Related]
25. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
26. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
[TBL] [Abstract][Full Text] [Related]
27. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
Hagedorn M; Hasche E; Kober B; Sander CA
Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
[TBL] [Abstract][Full Text] [Related]
28. Anetodermic mycosis fungoides: a new clinicopathological variant of mycosis fungoides.
Requena L; González-Guerra E; Angulo J; DeVore AE; Sangueza OP
Br J Dermatol; 2008 Jan; 158(1):157-62. PubMed ID: 17999702
[TBL] [Abstract][Full Text] [Related]
29. [Morphologic features of tumor stage lesions of mycosis fungoïdes (author's transl)].
Carbone A; Volpe R; Laurent M; Di Filippo L
Bull Cancer; 1982; 69(1):1-10. PubMed ID: 7074233
[TBL] [Abstract][Full Text] [Related]
30. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
[TBL] [Abstract][Full Text] [Related]
31. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
[TBL] [Abstract][Full Text] [Related]
32. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
Willemze R; Scheffer E; Meijer CJ
Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
[TBL] [Abstract][Full Text] [Related]
34. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
Moore PF; Olivry T; Naydan D
Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
[TBL] [Abstract][Full Text] [Related]
35. Poikilodermatous mycosis fungoides and atrophic large-plaque parapsoriasis exhibit similar abnormalities of T-cell antigen expression.
Lindae ML; Abel EA; Hoppe RT; Wood GS
Arch Dermatol; 1988 Mar; 124(3):366-72. PubMed ID: 3257858
[TBL] [Abstract][Full Text] [Related]
36. A subpopulation of Langerhans cells (CD1a+Lag-) increased in the dermis of plaque lesions of mycosis fungoides.
Fujita M; Horiguchi Y; Miyachi Y; Furukawa F; Kashihara-Sawami M; Imamura S
J Am Acad Dermatol; 1991 Sep; 25(3):491-9. PubMed ID: 1717524
[TBL] [Abstract][Full Text] [Related]
37. Leu-M1 antigen expression in advanced (tumor) stage mycosis fungoides.
Wieczorek R; Suhrland M; Ramsay D; Reed ML; Knowles DM
Am J Clin Pathol; 1986 Jul; 86(1):25-32. PubMed ID: 3088980
[TBL] [Abstract][Full Text] [Related]
38. T-cell subsets with a naive phenotype are selectively decreased in the peripheral blood of patients with mycosis fungoides.
Gilmore SJ; Benson EM; Kelly JW
J Invest Dermatol; 1991 Jan; 96(1):50-6. PubMed ID: 1987296
[TBL] [Abstract][Full Text] [Related]
39. [Panel of monoclonal antibodies to CD38 antigen].
Baryshnikov AIu; Dubinkin IV; Korotkova OV; Tupitsyn NN; Shvartsbergs AM
Biull Eksp Biol Med; 1989 Jan; 107(1):74-7. PubMed ID: 2783655
[TBL] [Abstract][Full Text] [Related]
40. Large cell mycosis fungoides at the tumor stage. Unusual T8, T4, T6 phenotypic expression.
Horiuchi Y; Tone T; Umezawa A; Takezaki S
Am J Dermatopathol; 1988 Feb; 10(1):54-8. PubMed ID: 2902810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
